Member Info for Vascular

This may explain why FDBK are also working closely with the private sector in UK, as they are also part of the solution.

https://www.linkedin.com/posts/paul-byrne-917a21148_the-cap-on-elective-funding-is-to-be-scrapped-activity-7313681512128786432-K_kr

This is the article I meant to post

“ 2 April 2025

Breaking News: Elective Care Funding Cap Scrapped

The NHS have today announced that the elective care funding cap, initially proposed by the government and NHS England as a measure to control costs, has been scrapped. Sir Jim Mackey, CEO of NHS England, confirmed the decision to cancel the proposed cap in a letter to health service leaders.

The letter said, “We will soon publish the response to the consultations on the NHS Standard Contract and payment rules for 2025-26. These will introduce a more flexible approach to planning elective activity, including scrapping the elective payment limit and enhancing activity management provisions within the contract."

This decision reversal will be welcomed by NHS Trusts, who now have more clarity regarding their funding for the 25/26 financial year to be able to deliver activity plans. ”

https://maxwellstanley.co.uk/resources/breaking-news-elective-care-funding-cap-scrapped

Sorry, this article is regarding payments to remove patients from waiting lists that are non urgent or no longer required to be on waiting lists.

It looks like you are correct….:😊

https://www.theguardian.com/society/2025/apr/10/hospitals-in-england-to-get-unlimited-incentive-payments-for-patients-taken-off-waiting-lists

Just spent ages buying in small quantities on IG ( between 1000 and and 5,000 share at a time.) so anything around the 9.8p mark are ALL buys. Good entry price, considering todays news.

Surrey and Sussex Healthcare goes live with imaging solution 9th April 25

https://www.digitalhealth.net/2025/04/surrey-and-sussex-healthcare-goes-live-with-imaging-solution/

“ Relationship:

While they operate in different areas of the digital health landscape, Bleepa and Sectra can be seen as complementary solutions. Bleepa can help with the communication and workflow aspects of medical imaging, while Sectra provides the technology for the imaging itself.

For example, a Surrey and Sussex NHS consortium procured Sectra's medical imaging system to support the seamless use of radiology imaging, and Sussex ICS is piloting Bleepa and CareLocker technology to tackle the issues of referral delays.”

I am not sure I agree. Ivoriginally bought shares around 12p when the company were releasing posative news and appearing on web casts, interviews etc ( what seemed like weekly) ! It seemed the company had water tight contracts, solid growing order book, fantastic possible revenus in March 25, talk if dividends and further distribution deals world wide! Plus, excitement about SOL and further collaboration with M and Watson ......today, the SP is approx 6p and may drop further ......everything else is unknown.......if it drops lower I'll buy some more as it can't be any more of a gamble than it was late last year at 30p plus......before the relenless good news fell of a cliff. What ifvuour wrong and a proportion of deals still in place, just waiting for M & W to decide on time lines! What if M& W are no longer interested ......others surely would be, wouldn't they if product delivery is so innovative and cutting edge! Just my thoughts .....its all a gamble as events these past six months have proven to us all. Gl vas

ShareTalk 1st April

"Comment: One can see INC clearing the decks as far as its obligations are concerned, something that now is patent issues are behind it, should see the company clear to push ahead fundamentally and as far as the share price is concerned."

https://www.share-talk.com/rns-hotlist-with-zak-mir-inc-he1-cns-stg-kzg/

A very positive chat about INC today on the Sunday Roast share discussion BLoG. Tim away, but due to appear next week. News rich period maybe due soon!

It did state that

"Commercial Update Highlights:

· First order will generate revenue to Incanthera of c. £2m and has doubled in size from Marionnaud's initial order for Skin + CELL products, from original 25,000 units* to 50,000 units: *One unit being one bottle of product i.e. face cream, hand cream etc.

o Strong demand from customers anticipated by Marionnaud's management.

o Enlarged order is being manufactured and on track for delivery to Marionnaud in Switzerland and Austria during Q2 2024."

This 50k order should have been delivered and paid for by September as on 26th Sept RNS. Commercial update....INC , now have orders of 350k, and they announce the launch will be extended to all 1,200 stores in Europe! Highly positive news at that time just when first delivery of the first 50k units were made worth £2 m. Do INC have £2 m now? Deliverycwithour payment would not be good start, and at a time of utmost confidence .

I recently thought i would try this share again, and i am hoping that progress and news flow will now be accelerated to some degree, and the ERF is extended for at least a few more years !!

Found a couple of references to FDBK over the weekend, if anyone is interested. Apologies if already posted. Mainly admin stuff but info i was unaware of.

https://www.gov.uk/government/publications/fletcher-mark-assistant-government-whip-the-cabinet-office-and-the-department-for-energy-and-net-zero/correspondence-from-acoba-to-mark-fletcher-breach-of-the-rules-feedback-medical.

8 Feb 2025 Termination of appointment of Nicholas Mayhew as a director on 8 February 2025

https://find-and-update.company-information.service.gov.uk/company/04025026/filing-history

Mayhew never held shares according to the Directors share holding register on LSE.

Hi PR, I watched most of the interview. The bit as you say that stood out for me was the The Questo about was the real reason the current governent wished to shut down NHS England was because they were a barrier to expanding the private sector in the NHS delivery. In fact they had a cap on budgets that could not be increased in monies oaudxeach year to the Private providers to ensure nhs largely remains public....however, labour wants to increase services , solutions on front line in the oricate sector to get their targets down and provide choices.......if true, could be good news.....plus labour want national contracts and not each health region researching , piloting, selecting smaller private contracts abd duplicating sane work accross nation.

It's early days but difficult to judge If this is Good news, Not SO good or neutral news. It's mostly about savings and a number will lose their jobs. However. FEEDBACK OFFER A BRILLIANT TEC TO SUPPORT FRONT LINE SERVICE SO HOPEFULLY WILL BE CONTKBUED .....SORRY ABOUT CAPS.

Anyone have a view on how today's news re: nhs England being taken back into NHS as a government department ( savings!!) Will effect the ERF which Tom in his last chat saud was likely to continue funding this next fibancial year BUT he will only be able to confirm when signed off in March 25. It's very important this fund continues for feedback into next financial year.

A more prosaic explanation for no news, is they are still in talks/ negotiating etc as any new developments regardless of positive or negative should be released to the market when available! So no news probably means there is no news at present. I agree months of talks without any serious legal involvement bodes well imo. Sounds more like a negotiation .....and if this negotiation involves specific regions which gave been given to M , for example then even further negotiations with M , I guess.

The share price today is approx as it was pre skin & cell / Watson announcement back in December 23.

Yes, we have this unknown claim against INT at present but the risk /reward of future business must count for something !!

The Skin &Cell / Watson deal and the anticipated new product range ( spray on sun cream etc) do not seem to be reflected in the sp, along with the possibility of a good outcome, and future products / opportunities.

What i do not understand is how a third party can make an apparently unsubstantiated claim against INC, and stop it trading, blocking millions of pounds of revenue . Surely, to stop a company from trading then a legal claim would have to be made in law by the company making the claim, and business would be suspended until after the claim was investigated.

This does not seem to be happening here ....no news, no legal claim, claim denied by INC and yet company acting as it has suspended business. Why! i am wondering if the third party is not a competitor but an entity much closer to home, and integral in the formulation process, maybe - chancing their luck maybe at what was probably the most crucial, sensitive period - between delivery of millions of units to M & Watson and maiden revenue collection of millions of pounds . Just thinking aloud here. GL Vas

Yes,it looks like a rollover! It was shown on IG as just one trade for 7, 258212 shares....

Anyone else see a 7 m trade go through at 15.57!!!! Is it a buy?

Morning All,

A while ago we were looking for some evidence that CC were still working alongside Genus , not sure how that progressed , apologies if this has already been highlighted.

This paragraph is copied for CCs Annual Report and Accounts 2024.

"Customers

CyanConnode’s works in ecosystems, going to market through customers, many of whom are well-known multinationals such as Schneider, Genus, IntelliSmart and the Monte Carlo Group. The Group integrates with electricity meters to provide its communication technology which makes the meters smart."

p13

chrome-extension://efaidnbmnnnibpcajpcglclefindmkaj/https://cyanconnode.com/wp-content/uploads/2024/07/268973-Cyanconnode-RA_interactive.pdf

Regarding this from RNS on 6th Nov 24.

"The company advises that it has received unsupported allegations from a third party concerning potential patent infringement in relation to the formulation of the Skin + Cell range of products. The Company considers the unsupported allegations to be without merit".

I am amazed that it seems anyone can make "unsupported allegations" towards another company causing the share price to crash from 15p to less than 5p, stopping the company from a game changing rollout and trading and hence potential future significant profits and could put the company in financial risk...all this without any evidence being provided to support the allegations towards INC. This does not seem fair, and means any competitor could make such allegations - as i bet the company behind this are still trading .................does anyone have any experience of this, as IMO if INC are found innocent of these unfounded allegations there must be legal litigation to get compensation by INC.

The only thing that would change this is if the allegations are in fact founded on something tangible and the wording in the RNS "without Merit" are a red herring. Anyone come across a patent infringement situation similar to this one, where the accused was proven wrong and compensation was sought....what happened , what were the timelines ....GL Vas